Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
NCT02610582
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Achromatopsia
Interventions
DRUG:
rAAV.hCNGA3
Sponsor
STZ eyetrial
Collaborators
[object Object]
[object Object]